Purpose We aimed to quantify the relative risk of progression from mild cognitive impairment
(MCI) to dementia in people with and without diabetes, and with and without the MetS …

Both type 1 and type 2 diabetes have been associated with reduced performance on
multiple domains of cognitive function and with structural abnormalities in the brain. With an …

Cognitive dysfunctions such as mild cognitive impairment (MCI), Alzheimer's disease (AD),
and other forms of dementia are recognized as common comorbidities of type 2 diabetes …

Glucocorticoid action on target tissues is determined by the density of “nuclear” receptors
and intracellular metabolism by the two isozymes of 11β-hydroxysteroid dehydrogenase …

There is strong evidence that diabetes mellitus increases the risk of cognitive impairment
and dementia. Insulin signaling dysregulation and small vessel disease in the base of …

Diabetes mellitus is associated with an increase in the risk of dementia and the proportion of
patients who convert from mild cognitive impairment (MCI) to dementia. In addition to MCI …

Type 2 diabetes is associated with cognitive dysfunction and structural brain changes.
Abnormalities in glucose regulation are involved in several complications related to type 2 …

Importance Schizophrenia is associated with cognitive dysfunction and cardiovascular risk
factors, including metabolic syndrome (MetS) and its constituent criteria. Cognitive …

Type 2 diabetes is associated with dementia, and also with more slight cognitive
decrements. In this Review we discuss trajectories from normal cognition to dementia in …

The human body is populated by myriads of microorganisms throughout its surface and in
the cavities connected to the outside. The microbial colonisers of the intestine (microbiota) …